The antihyperglycemic drug α-lipoic acid stimulates glucose uptake via both GLUT4 translocation and GLUT4 activation: Potential role of p38 mitogen-activated protein kinase in GLUT4 activation

Diabetes

Volumn 50, Issue 6, 2001, Pages 1464-1471

  Konrad, Daniel ^a,b   Somwar, Romel ^a,b   Sweeney, Gary ^a   Yaworsky, Karen ^a   Hayashi, Michiko ^a   Ramlal, Toolsie ^a   Klip, Amira ^a,b  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 HYDROXYPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; 4 ETHYL 2 (4 METHOXYPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; DEOXYGLUCOSE; GLUCOSE TRANSPORTER; GLUCOSE TRANSPORTER 1; GLUCOSE TRANSPORTER 4; INSULIN; ISOENZYME; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; MITOGEN ACTIVATED PROTEIN KINASE P38; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL KINASE; PROTEIN SERINE THREONINE KINASE; THIOCTIC ACID; UNCLASSIFIED DRUG; WORTMANNIN;

ADIPOCYTE; ANIMAL CELL; ARTICLE; CELL STRAIN 3T3; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; GLUCOSE TRANSPORT; MOUSE; MYOTUBE; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0034987312     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.50.6.1464     Document Type: Article

References (44)

1. Oral administration of RAC-alpha-lipoic acid modulates insulin sensitivity in patients with type-2 diabetes mellitus: A placebo-controlled pilot trial
2. α-Lipoic acid treatment decreases serum lactate and pyruvate concentrations and improves glucose effectiveness in lean and obese patients with type 2 diabetes
3. Treatment of symptomatic diabetic polyneuropathy with the antioxidant α-lipoic acid: A 7-month multicenter randomized controlled trial (ALADIN III Study)
4. Treatment of diabetic polyneuropathy with the antioxidant thioctic acid (alpha-lipoic acid): A two year multicenter randomized double-blind placebo-controlled trial (ALADIN II). Alpha Lipoic Acid in Diabetic Neuropathy
5. The antioxidant α-lipoic acid enhances insulin-stimulated glucose metabolism in insulin-resistant rat skeletal muscle
6. Differential effects of lipoic acid stereoisomers on glucose metabolism in insulin-resistant skeletal muscle
7. Effects of a unique conjugate of alpha-lipoic acid and gamma-linolenic acid on insulin action in obese Zucker rats
8. Lipoic acid reduces glycemia and increases muscle GLUT4 content in streptozotocin-diabetic rats
9. Stimulation of glucose uptake by the natural coenzyme alpha-lipoic acid/thioctic acid: Participation of elements of the insulin signaling pathway
10. Engagement of the insulin-sensitive pathway in the stimulation of glucose transport by alpha-lipoic acid in 3T3-L1 adipocytes
11. The effects of wortmannin on rat skeletal muscle: Dissociation of signaling pathways for insulin- and con contraction-activated hexose transport
12. Wortmannin inhibits insulin-stimulated but not contraction-stimulated glucose transport activity in skeletal muscle
13. Does insulin-induced increase in the amount of plasma membrane GLUTs quantitatively account for insulin-induced increase in glucose uptake?
14. Overexpression of Rad inhibits glucose uptake in cultured muscle and fat cells
15. Protein synthesis inhibitors activate glucose transport without increasing plasma membrane glucose transporters in 3T3-L1 adipocytes
16. Activation of cell surface glucose transporters measured by photoaffinity labeling of insulin-sensitive 3T3-L1 adipocytes
17. The role of glycogen synthase kinase 3β in insulin-stimulated glucose metabolism
18. An inhibitor of p38 mitogen-activated protein kinase prevents insulin-stimulated glucose transport but not glucose transporter translocation in 3T3-L1 adipocytes and L6 myotubes
19. Evidence for a role of stress-activated protein kinase in the regulation of insulin-stimulated glucose transport
20. GLUT4 translocation by insulin in intact muscle cells: Detection by a fast and quantitative assay
21. Activation of p38 mitogen-activated protein kinase α and β by insulin and contraction in rat skeletal muscle: Potential role in the stimulation of glucose transport
22. Temporal activation of p70 S6 kinase and Akt1 by insulin: PI 3-kinase- dependent and -independent mechanisms
23. Glucose transport in human skeletal muscle cells in culture. Stimulation by insulin and metformin
24. Stimulation of glucose uptake and increased plasma membrane content of glucose transporters in L6 skeletal muscle cells by the sulfonylureas gliclazide and glyburide
25. Regulation of glucose transport in cultured muscle cells by novel hypoglycemic agents
26. p38 MAP kinases: Beyond the stress response
27. Pro-inflammatory cytokines and environmental stress cause p38 mitogen-activated protein kinase activation by dual phosphorylation on tyrosine and threonine
28. Characterization of the structure and function of a new mitogen-activated protein kinase (p38β)
29. Mechanism of activation of protein kinase B by insulin and IGF-1
30. Protein kinase B/Akt participates in GLUT4 translocation by insulin in L6 myoblasts
31. Acute and chronic effects of troglitazone (CS-045) on isolated rat ventricular cardiomyocytes
32. The new antidiabetic drug MCC-555 acutely sensitizes insulin signaling in isolated cardiomyocytes
33. Troglitazone regulation of glucose metabolism in human skeletal muscle cultures from obese type II diabetic subjects
34. Acute non-insulin-like stimulation of rat muscle glucose metabolism by troglitazone in vitro
35. GLUT-4myc ectopic expression in L6 myoblasts generates a GLUT-4-specific pool conferring insulin sensitivity
36. Insulin activates a p21-activated kinase in muscle cells via phosphatidylinositol 3-kinase
37. Inhibition of the translocation of GLUT1 and GLUT4 in 3T3-L1 cells by the phosphatidylinositol 3-kinase inhibitor, wortmannin
38. Expression of a constitutively active Akt Ser/Thr kinase in 3T3-L1 adipocytes stimulates glucose uptake and glucose transporter 4 translocation
39. Potential role of protein kinase B in glucose transporter 4 translocation in adipocytes
40. A role for protein kinase Bbeta/Akt2 in insulin-stimulated GLUT4 translocation in adipocytes
41. SB 203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stresses and interleukin-1
42. FGF and stress regulate CREB and ATF-1 via a pathway involving p38 MAP kinase and MAPKAP kinase-2
43. Regulation and function of p38 protein kinase in isolated canine gastric parietal cells
44. Effects of the inhibition of p38/RK MAP kinase on induction of five fos and jun genes by diverse stimuli